Quantification System provides RNA detection.
Press Release Summary:
Comprised of assay kit and probe set, QuantiGene® 2.0 RNA Quantification System detects gene expression knockdown. Assay avoids variation errors commonly seen when extracting and amplifying target sequences, enabling pharmaceutical and academic researchers to maximize efficiency. System is suited for variety of life science applications, including predictive toxicology and microarray validation.
Original Press Release:
Sigma Introduces QuantiGene(R) 2.0 RNA Quantification System
ST. LOUIS, March 1 /-- Sigma, a division of Sigma-Aldrich (NASDAQ:SIAL), a leading $1.8 billion Life Science and High Technology company, is pleased to introduce the QuantiGene(R) 2.0 RNA Quantification System (http://sigma.com/quantigene). The technology is comprised of an assay kit and probe set that detect gene expression knockdown, providing a unique approach for RNA quantification. "QuantiGene(R) 2.0 contributes to biological drug discovery as an optimal system for high-throughput screening," said Keith Jolliff, Director of Strategic Marketing. "The assay avoids the variation errors commonly seen when extracting and amplifying target sequences, enabling pharmaceutical and academic researchers to maximize efficiency. Sigma is committed to serving the genomics research community with best-in-class technologies." The QuantiGene(R) 2.0 RNA Quantification System has been used to quantitate gene expression in a variety of life science applications, including predictive toxicology, microarray validation, and RNAi knockdown. Sigma provides a full range of RNA interference research tools, from gene silencing to validation. The MISSION(R) RNAi product line offers numerous options for gene knockdown including custom siRNA, siRNA panels and various shRNA formats. Gene knockdown can then be confirmed by QuantiGene 2.0 system's unique approach to RNA detection and quantification. For information on MISSION RNAi products, please visit our Web site at sigma.com/rnai. About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. The Company has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 35 countries and has 7,300 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award-winning Web site at sigma-aldrich.com. QuantiGene is a registered trademark of Bayer. MISSION is a registered trademark belonging to Sigma-Aldrich Co. and its affiliate Sigma-Aldrich Biotechnology LP. CONTACT: Sean Battles of Sigma-Aldrich, +1-314-286-7616, sean.battles@sial.com Web site: www.sigma-aldrich.com/ http://www.panomics.com/
